Member Info for ShearClass

This feels primed right now, a couple of decent buys and the ask is raised, any decent buying and it'll be back in the 20's very quickly.

Seller certainly appears to be gone, hence why it's so difficult to buy now - has been NT to buy for most of the last hour!

I don't understand how Kibo will only hold 55% of MED post IPO, if they currently hold 100% of MED and MED are raising £5m at a £23m valuation? 5/23 = 0.218, so 22% should be owned by the IPO participants and the rest by Kibo? Anyone able to clarify this?

Good bit of churn ongoing after the breakout, happy to be in from the 34p range and expecting a further rise to 53p to complete the bowl formation over the course of the next month or so (although could happen a lot sooner). There aren't many better options around at present that's for sure.

Hitherbroom, so to confirm you sold your shares and then bought them back straight away to save on capital gains? Were both transactions outside an ISA?

Ouch, 100k just sold at 6.31, this is now at an all time low... If they don't make an imminent announcement to clarify the situation then it appears the equity is going to be valued at close to zero.

Some huge trades posted there in the last half hour, looks to me as though a seller has been taken out at 33.5p. Either way excellent volume again which is one of the factors which attracted me here. The simple fact is STX have a drug which is FDA approved and they have the cash required to launch in the US, that alone is enough to justify a much higher market cap than they have at present.

Matml74, not sure who you're trying to kid by quoting the December death spiral financing agreement... However, given the current share price the important part of that agreement is below;

"Both parties may postpone an investment by the Investor in relation to its third and fourth tranches of investment for up to 90 days on one occasion only during the term of the Agreement. In the case of the Investor, it may also postpone the second, third and fourth tranches of investment for up to 60 days if the market price of the Company's Shares is equal to or less than a base price of £0.13 per Share (in the case of the third and fourth tranches) and £0.05 per Share (in the case of the second tranche) for two consecutive trading days. If during the period of postponement the market price does not recover to equal or exceed that price for an agreed period then the Investor will have the right to elect to terminate the Agreement."

If SAE can't draw down further from this agreement they'll have to raise cash another way... and who is going to lend to them if they can't get planning permission for Uskmouth yet retain the decommissioning costs? I think you'll have a hard time trying to argue anything other than that they are in a very difficult situation at present!

Thanks Pickuzawinnah, yes I think it fair to be sceptical of the 218p (they do state this won't be reached until the market is fully convinced on the US roll out to be fair). The fact is STX have FDA approval for a drug with a large addressable market, I can't imagine there are many companies with FDA approval and a market cap of £75m... I suspect that's why we have such impressive volume coming in.

You're an odd one Sotolo, very glass half empty... if you think it's fair value at the current price then why don't you sell? An even more bizarre statement to make if you've bought higher than this?!

Have joined here this morning. Edison have a price target of 218p which is crazy upside from current levels. Also worth remembering that this opened at £1.80 on the morning of their FDA approval back in 2019, this equated to a market cap of £201m, which is worth 93p today after the recent dilution.

Whichever way you look at it, there appears plenty of value to buying at 34p / £74m cap. A recovery would also be the third time it's swung from under 50p to over £1 in the last three years, so it's been a fruitful share if you have bought at the right time...

Because it was front run from 75p by someone who got wind of the news...

The problem here is the debt - £10.3m at the end of 2019... check out the 2019 annual accounts. Has great potential but likely won't go anywhere until this is sorted out. It also explains why they've been unable to raise capital via traditional means & had to resort to another loan to provide short term cash flow (the Vulpe Loan).

If you had cash to spare then buying this company would be a very interesting proposition...I'd imagine that what Martin Diggle has designs on doing.

One for the watchlist.

Indeed, profitable, with a new CEO at the helm & operating in a very interesting area - I'm very intrigued as to the level of royalties generated from Thermo Fisher...

Used to be 70p back in 2015 with 196m shares in issue vs 296m today, so very little dilution has taken place, could really move if we get some volume today!

Appears to be a decent buy in level this morning at only 10% above the major holders.

The significant shareholder list is something special;

https://www.advancedadvt.com/investors/shareholder-information/default.aspx

The major issue that is looming into view is the South Africa variant, vaccine efficacy against this strain is much lower and scientists believe 10-20% of cases in France are as a result of it. If spread continues and reduced efficacy is confirmed then foreign travel is a no go this summer.

What I also must call out is the stupidity of that daily mail column from 'Mr Money Maker'. He talks about IAG being valued at 495p pre covid and that despite the price doubling since the summer lows of £1, it remains capable of moving up strongly from here... why is he talking about share price and not market cap?????

At the 495p peak of 2018 (it was as low as 250p in 2016), there were 1.983b shares in issue, giving a market cap of £9.8b

At the current price of 207p, there are 4.97b shares now in issue, giving a market cap of £10.2b

So the current equity value of the company is already higher than it was at it's peak in 2018. Yet the fundamentals are significantly worse regardless of what happens this summer. In addition;

- There will be no dividends before the end of 2023
- Net assets at the end of 2020 were £1.3b, versus £6.9b at the end of 2019.

So why would the share price move strongly higher? Personally I think it appears to be defying gravity at the moment...

Yep, the irony being the wording of the last years RNS "Given the unprecedented market volatility and lack of liquidity due to Covid-19 there has not been sufficient demand to successfully complete the planned placing."

Certainly no issue with liquidity now! The antics that go on really make me laugh sometimes. I would bet that 99% of those that have bought this week have no idea such an arrangement has been agreed.

Yeah that video is embarrassing - the bigger issue is that according to the following RNS he has a lock in arrangement for 64m shares that expires today... https://www.londonstockexchange.com/news-article/FAR/director-lock-in-orderly-marketing-arrangement/14467958?lang=en

I don't short shares, but if I did I would be sorely tempted right now!

They’ve been invested since pre 2018 and didn’t sell any in the IPO, my guess is they’ve taken their stake out...

http://www.rcpinvest.com/new-blog/2018/2/24/test-post-2

Mark Randall, Managing Director of RCP, remarked “We look forward to supporting Kevin and his team as AMTE commercializes its technology, and brings these next gen benefits to UK industry. RCP always looks for disruptive technology that can help make the world a better place.”

On this date last year you could have bought Ceres for £2.30... so to anyone complaining about a £181m growth capital raise at £10.50, all I have to say is get real... Sure the dilution is 10%, but that's only relevant if the share price decreases in proportion to the amount raised. If you've bought the spike to £16 then again, that's an important lesson in timing or dollar cost averaging. Also, the deal announced this morning would clearly have been factored into negotiations.

I'm happy to let this boat sail, there will be many more new technologies that will change the world. Good luck to all genuine long term holders, this should continue to do very well.